[{"address1": "#21-1344 Summer Street", "city": "Halifax", "state": "NS", "zip": "B3H 0A8", "country": "Canada", "phone": "902 442 4655", "website": "https://appilitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin which is in Phase III clinical trials for the treatment of cutaneous leishmaniasis; and ATI-1701, which is a live-attenuated vaccine that is in preclinical trials for the treatment of francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Donald D. Cilla Jr., M.B.A., Pharmd", "title": "CEO, President & Director", "fiscalYear": 2024, "totalPay": 430151, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth G. Howling", "title": "Acting Chief Financial Officer", "fiscalYear": 2024, "totalPay": 352204, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary S. Nabors Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "totalPay": 394645, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl  Gelhaus Ph.D.", "title": "Director of Non-Clinical Research", "fiscalYear": 2024, "totalPay": 216800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arthur  Baran", "title": "Director of New Product Development", "fiscalYear": 2024, "totalPay": 225602, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jenna  McNeil", "title": "Corporate Affairs & Communications Manager", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.014, "open": 0.01, "dayLow": 0.01, "dayHigh": 0.0108, "regularMarketPreviousClose": 0.014, "regularMarketOpen": 0.01, "regularMarketDayLow": 0.01, "regularMarketDayHigh": 0.0108, "payoutRatio": 0.0, "beta": -0.467, "forwardPE": -0.28, "volume": 82500, "regularMarketVolume": 82500, "averageVolume": 44272, "averageVolume10days": 12420, "averageDailyVolume10Day": 12420, "bid": 0.0104, "ask": 0.013, "bidSize": 50000, "askSize": 10000, "marketCap": 1697724, "fiftyTwoWeekLow": 0.009, "fiftyTwoWeekHigh": 0.035, "priceToSalesTrailing12Months": 16.902363, "fiftyDayAverage": 0.0148, "twoHundredDayAverage": 0.0218, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12739645, "profitMargins": 0.0, "floatShares": 106833026, "sharesOutstanding": 121266000, "heldPercentInsiders": 0.00062, "heldPercentInstitutions": 0.11841, "impliedSharesOutstanding": 149760000, "bookValue": -0.11, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -2624692, "trailingEps": -0.01, "forwardEps": -0.05, "enterpriseToRevenue": 126.835, "enterpriseToEbitda": -1.265, "52WeekChange": -0.36363637, "SandP52WeekChange": 0.1116153, "quoteType": "EQUITY", "currentPrice": 0.014, "recommendationKey": "none", "totalCash": 1228244, "totalCashPerShare": 0.01, "ebitda": -10071599, "totalDebt": 12294417, "quickRatio": 0.185, "currentRatio": 0.192, "totalRevenue": 100443, "revenuePerShare": 0.001, "returnOnAssets": -2.78711, "grossProfits": 100443, "freeCashflow": -8534213, "operatingCashflow": 868816, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": 201.01198, "financialCurrency": "CAD", "symbol": "APLIF", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Appili Therapeutics Inc.", "longName": "Appili Therapeutics Inc.", "regularMarketChange": 0.0, "regularMarketDayRange": "0.01 - 0.0108", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 44272, "fiftyTwoWeekLowChange": 0.005000001, "fiftyTwoWeekLowChangePercent": 0.55555564, "fiftyTwoWeekRange": "0.009 - 0.035", "fiftyTwoWeekHighChange": -0.021, "fiftyTwoWeekHighChangePercent": -0.59999996, "fiftyTwoWeekChangePercent": -36.363636, "earningsTimestampStart": 1755633600, "earningsTimestampEnd": 1755633600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.01, "epsForward": -0.05, "fiftyDayAverageChange": -0.0007999996, "fiftyDayAverageChangePercent": -0.054054026, "twoHundredDayAverageChange": -0.0078, "twoHundredDayAverageChangePercent": -0.35779816, "priceToBook": -0.12727273, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1752264000, "exchange": "PNK", "messageBoardId": "finmb_330222442", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.014, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1610116200000, "displayName": "Appili Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]